---
figid: PMC4197858__emmm0006-1105-f3
figlink: /pmc/articles/PMC4197858/figure/fig03/
number: F3
caption: '(A) High glucose levels in diabetes pushes glycolytic flux and cause ROS
  production and AGE formation. (B) Metabolic alterations that cause eNOS dysfunction
  mediate atherosclerosis pathogenesis. Asymmetric dimethylarginine (ADMA) competes
  with arginine for binding to eNOS. Arginase expression is increased and eNOS expression
  is decreased, leading to reduced eNOS activity. 1C metabolism and mevalonate metabolism
  provide eNOS coupling co-factors and inhibit ROS production. The mevalonate pathway
  also provides farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP),
  required for GTPase prenylation. For clarity, not all metabolites and enzymes of
  the depicted pathways are shown. Green font / bold line: upregulated, red font /
  broken line: downregulated. Abbreviations: as in Figure . BH2: dihydrobiopterin;
  BH4: tetrahydrobiopterin; ADMA: asymmetric dimethylarginine; CoQ10: coenzyme Q10;
  DDAH: dimethylarginine dimethylaminohydrolase; DHF: dihydrofolate; DHFR: dihydrofolate
  reductase; FPP: farnesyl pyrophosphate; GGPP: geranylgeranyl pyrophosphate; GTP:
  Guanosine triphosphate; HMGCR: hydroxymethylglutaryl coenzyme A reductase; PRMT:
  protein arginine methyltransferase.'
pmcid: PMC4197858
papertitle: Principles of targeting endothelial cell metabolism to treat angiogenesis
  and endothelial cell dysfunction in disease.
reftext: Jermaine Goveia, et al. EMBO Mol Med. 2014 Sep;6(9):1105-1120.
pmc_ranked_result_index: '55656'
pathway_score: 0.9421221
filename: emmm0006-1105-f3.jpg
figtitle: Principles of targeting endothelial cell metabolism to treat angiogenesis
  and endothelial cell dysfunction in disease
year: '2014'
organisms: Homo sapiens
ndex: ed8ef472-de9a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4197858__emmm0006-1105-f3.html
  '@type': Dataset
  description: '(A) High glucose levels in diabetes pushes glycolytic flux and cause
    ROS production and AGE formation. (B) Metabolic alterations that cause eNOS dysfunction
    mediate atherosclerosis pathogenesis. Asymmetric dimethylarginine (ADMA) competes
    with arginine for binding to eNOS. Arginase expression is increased and eNOS expression
    is decreased, leading to reduced eNOS activity. 1C metabolism and mevalonate metabolism
    provide eNOS coupling co-factors and inhibit ROS production. The mevalonate pathway
    also provides farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP),
    required for GTPase prenylation. For clarity, not all metabolites and enzymes
    of the depicted pathways are shown. Green font / bold line: upregulated, red font
    / broken line: downregulated. Abbreviations: as in Figure . BH2: dihydrobiopterin;
    BH4: tetrahydrobiopterin; ADMA: asymmetric dimethylarginine; CoQ10: coenzyme Q10;
    DDAH: dimethylarginine dimethylaminohydrolase; DHF: dihydrofolate; DHFR: dihydrofolate
    reductase; FPP: farnesyl pyrophosphate; GGPP: geranylgeranyl pyrophosphate; GTP:
    Guanosine triphosphate; HMGCR: hydroxymethylglutaryl coenzyme A reductase; PRMT:
    protein arginine methyltransferase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DDAH1
  - MTHFR
  - AR
  - NOS3
  - DHFR
  - G6PD
  - RHOA
  - ACSM3
  - UBIAD1
  - MET
  - HMGCR
  - SLC2A1
  - LHX4
  - L-arginine
  - Cholesterol
  - Folate
  - Fructose
  - Glucose
  - Glycine
  - Mevalonate
  - Methylglyoxal
  - Pyruvate
  - Serine
  - Sorbitol
  - Superoxide
  - UDP
genes:
- word: DDAH
  symbol: DDAH
  source: hgnc_alias_symbol
  hgnc_symbol: DDAH1
  entrez: '23576'
- word: MTHFR
  symbol: MTHFR
  source: hgnc_symbol
  hgnc_symbol: MTHFR
  entrez: '4524'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: DHFR
  symbol: DHFR
  source: hgnc_symbol
  hgnc_symbol: DHFR
  entrez: '1719'
- word: G6PD
  symbol: G6PD
  source: hgnc_symbol
  hgnc_symbol: G6PD
  entrez: '2539'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: SAH
  symbol: SAH
  source: hgnc_prev_symbol
  hgnc_symbol: ACSM3
  entrez: '6296'
- word: Ubiad1
  symbol: UBIAD1
  source: hgnc_symbol
  hgnc_symbol: UBIAD1
  entrez: '29914'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: HMGCR
  symbol: HMGCR
  source: hgnc_symbol
  hgnc_symbol: HMGCR
  entrez: '3156'
- word: eNOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: GLUT1
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: GSH4
  symbol: Gsh4
  source: hgnc_alias_symbol
  hgnc_symbol: LHX4
  entrez: '89884'
chemicals:
- word: L-arginine
  source: MESH
  identifier: D001120
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Folate
  source: MESH
  identifier: D005492
- word: Fructose
  source: MESH
  identifier: D005632
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glycine
  source: MESH
  identifier: D005998
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: Methylglyoxal
  source: MESH
  identifier: D011765
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Serine
  source: MESH
  identifier: D012694
- word: Sorbitol
  source: MESH
  identifier: D013012
- word: Superoxide
  source: MESH
  identifier: D013481
- word: UDP
  source: MESH
  identifier: D014530
diseases: []
figid_alias: PMC4197858__F3
redirect_from: /figures/PMC4197858__F3
figtype: Figure
---
